Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
2002 3
2003 3
2004 5
2005 2
2006 5
2007 1
2008 4
2009 5
2010 1
2011 8
2012 7
2013 13
2014 10
2015 7
2016 12
2017 28
2018 17
2019 9
2020 26
2021 17
2022 15
2023 25
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

198 results

Results by year

Filters applied: . Clear all
Page 1
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitis.
Suda G, Baba M, Yamamoto Y, Sho T, Ogawa K, Kimura M, Hosoda S, Yoshida S, Kubo A, Fu Q, Yang Z, Tokuchi Y, Kitagataya T, Maehara O, Ohnishi S, Yamada R, Ohara M, Kawagishi N, Natsuizaka M, Nakai M, Morikawa K, Furuya K, Suzuki K, Izumi T, Meguro T, Terashita K, Ito J, Kobayashi T, Tsunematsu I, Sakamoto N. Suda G, et al. Among authors: ito j. J Med Virol. 2023 Feb;95(2):e28452. doi: 10.1002/jmv.28452. J Med Virol. 2023. PMID: 36597900
Phosphatidylcholine in bile-derived small extracellular vesicles as a novel biomarker of cholangiocarcinoma.
Muraki R, Morita Y, Ida S, Kitajima R, Furuhashi S, Takeda M, Kikuchi H, Hiramatsu Y, Takanashi Y, Hamaya Y, Sugimoto K, Ito J, Kawata K, Kawasaki H, Sato T, Kahyo T, Setou M, Takeuchi H. Muraki R, et al. Among authors: ito j. Cancer Med. 2023 Jun;12(12):13007-13018. doi: 10.1002/cam4.5973. Epub 2023 Apr 25. Cancer Med. 2023. PMID: 37096775 Free PMC article.
Hepatic Angiosarcoma with Peliosis Hepatis.
Kitsugi K, Kawata K, Matsumoto M, Umemura M, Hanaoka T, Yamashita M, Takatori S, Ito J, Ohta K, Chida T, Noritake H, Suda T. Kitsugi K, et al. Among authors: ito j. Intern Med. 2023 Apr 15;62(8):1157-1166. doi: 10.2169/internalmedicine.0315-22. Epub 2022 Sep 6. Intern Med. 2023. PMID: 36070948 Free PMC article.
Enzyme replacement with transferrin receptor-targeted α-L-iduronidase rescues brain pathology in mucopolysaccharidosis I mice.
Kida S, Koshimura Y, Yoden E, Yoshioka A, Morimoto H, Imakiire A, Tanaka N, Tanaka S, Mori A, Ito J, Inoue A, Yamamoto R, Minami K, Hirato T, Takahashi K, Sonoda H. Kida S, et al. Among authors: ito j. Mol Ther Methods Clin Dev. 2023 May 12;29:439-449. doi: 10.1016/j.omtm.2023.05.010. eCollection 2023 Jun 8. Mol Ther Methods Clin Dev. 2023. PMID: 37251981 Free PMC article.
Sixty-minute uroflowmetry: A pilot study.
Kaiho Y, Ito J, Mikami J, Kohada Y, Kusumoto H, Sato M. Kaiho Y, et al. Among authors: ito j. Int J Urol. 2020 Nov;27(11):1050-1051. doi: 10.1111/iju.14323. Epub 2020 Aug 17. Int J Urol. 2020. PMID: 32808331 No abstract available.
Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment.
Hosoda S, Suda G, Sho T, Ogawa K, Kimura M, Yang Z, Yoshida S, Kubo A, Tokuchi Y, Kitagataya T, Maehara O, Ohnishi S, Nakamura A, Yamada R, Ohara M, Kawagishi N, Natsuizaka M, Nakai M, Morikawa K, Furuya K, Baba M, Yamamoto Y, Suzuki K, Izumi T, Meguro T, Terashita K, Ito J, Miyagishima T, Sakamoto N. Hosoda S, et al. Among authors: ito j. Liver Cancer. 2022 Oct 31;12(2):156-170. doi: 10.1159/000527759. eCollection 2023 Jun. Liver Cancer. 2022. PMID: 37325489 Free PMC article.
198 results